ストックスクリーナーアプリを入手
41.94
3.68%
1.49
前日終値:
$40.45
開ける：
$40.57
24時間の取引高:
3.52M
Relative Volume:
1.36
時価総額：
$6.36B
収益：
$3.24B
当期純損益:
$304.90M
株価収益率:
20.16
EPS:
2.08
ネットキャッシュフロー:
$156.70M
1週間 パフォーマンス:
+3.43%
1か月 パフォーマンス:
+2.47%
6か月 パフォーマンス:
-26.79%
1年 パフォーマンス:
-34.70%
1日の値動き範囲:
$40.41
$42.05
1週間の範囲:
$34.62
$42.05
52週間の値動き範囲:
$34.10
$72.94
Bruker Corp Stock (BRKR) Company Profile
BRKR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
41.94 | 6.13B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-10 | 開始されました | UBS | Neutral |
| 2024-12-05 | アップグレード | Goldman | Sell → Neutral |
| 2024-10-15 | 開始されました | Barclays | Overweight |
| 2024-09-30 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2022-10-21 | 開始されました | UBS | Buy |
| 2022-08-22 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-06-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2021-02-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 開始されました | Goldman | Sell |
| 2020-11-16 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | ダウングレード | Cleveland Research | Buy → Neutral |
| 2020-04-02 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | ダウングレード | Needham | Strong Buy → Hold |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-06-24 | 繰り返されました | Needham | Strong Buy |
| 2019-06-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Peer Perform |
| 2019-05-06 | 繰り返されました | Needham | Strong Buy |
| 2019-05-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | アップグレード | UBS | Sell → Neutral |
| 2019-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 繰り返されました | BTIG Research | Buy |
| 2019-01-03 | 開始されました | Needham | Strong Buy |
すべてを表示
Bruker Corp (BRKR) 最新ニュース
Is Bruker Corporation stock a growth or value playDouble-digit growth - jammulinksnews.com
Bruker Corp. (BRKR) Dismal Q2 Earnings Weighs On Sentiment - MSN
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Bruker First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $46 to $50 - 富途牛牛
S&P 500 eyes new record, Opendoor skyrockets, Bruker plummets - Yahoo Finance
Wall Street Extends Records, Gold Rallies To $3,400: What's Moving Markets Monday? - Benzinga
Why Bruker (BRKR) Shares Are Getting Obliterated Today - Yahoo Finance
Bruker Projects Q2 Revenue Of $795M–$798M; Non-GAAP EPS Expected At $0.32–$0.34, Down $0.19 YoY Amid $0.06 FX Impact - 富途牛牛
Bruker stock plunges as Stifel maintains Hold rating amid Q2 revenue miss - Investing.com Canada
Bruker Visibility, Credibility in Focus After Preliminary 2Q Results -- Market Talk - 富途牛牛
Bruker tumbles as preliminary Q2 results show revenue decline By Investing.com - Investing.com Canada
Bruker tumbles as preliminary Q2 results show revenue decline - Investing.com
Press Release: Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025 - 富途牛牛
Bruker Q2 Earnings Show $798M Revenue as Biopharma Weakness, Academic Slowdown Impact Results - Stock Titan
What analysts say about Bruker Corporation stockSkyrocketing returns - PrintWeekIndia
What drives Bruker Corporation stock priceDouble-digit growth - jammulinksnews.com
Bruker Corporation Stock Analysis and ForecastConsistent double returns - jammulinksnews.com
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
10x Genomics Ends UPC Patent Fight With Bruker - Law360
March 2026 Options Now Available For Bruker (BRKR) - Nasdaq
Rare Earth Metals concept stocks continued to rise at the start of the day, as the United States aims to accelerate the construction of the Rare Earth Metals supply chain, and the Bruker Corp Rare Earth Metals project in Wyoming has officially launched. - 富途牛牛
Bruker Corp Shares Surge 3.51% Amid Analyst Estimates and GF Value Prediction - AInvest
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Acquires Majority Stake in RECIPE, Boosts Diagnostic and Drug Monitoring Capabilities - Yahoo Finance
Bruker: Weakness In Academic Research Shadows Near-Term Growth; Initiate With 'Hold' - Seeking Alpha
Bruker price target lowered to $50 from $61 at BofA - Yahoo Finance
BRKR: B of A Securities Updates Price Target for Bruker | BRKR Stock News - GuruFocus
Bruker (BRKR) Price Target Reduced by BofA Amid Market Uncertain - GuruFocus
A Glimpse Into The Expert Outlook On Bruker Through 9 Analysts - Benzinga
AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology - Insider Monkey
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands - Yahoo Finance
10x Genomics Settles Patent Dispute With Bruker - Insider Monkey
First Week of August 15th Options Trading For Bruker (BRKR) - Nasdaq
Bruker Corp (BRKR) Shares Up 3.22% on Jun 18 - GuruFocus
Q1 Earnings Outperformers: Bruker (NASDAQ:BRKR) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Dairy Analyzer | Bruker Optics Inc. | Products - Photonics Spectra
Bruker Corp (BRKR) Trading 4.64% Higher on Jun 10 - GuruFocus
Bruker Stock Set to Gain From Acquisition of Austria's biocrates - Yahoo Finance
Bruker Leads 3 Growth Stocks With Strong Insider Ownership - Yahoo Finance
Bruker acquires Austria based biocrates - MSN
Bruker introduces new timsUltra AIP System at ASMS 2025 - SelectScience
Bruker at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
biocrates life sciences ag becomes part of Bruker Group - SelectScience
Bruker launches revolutionary timsOmni mass spectrometer at ASMS 2025 - SelectScience
New proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025 - SelectScience
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions - Insider Monkey
Bruker invests in diagnostics, unveils new analysis platform By Investing.com - Investing.com Nigeria
Bruker's New Mass Spectrometry Platform Achieves 40% Higher Detection Rate for Environmental Contaminants - Stock Titan
Bruker (BRKR) Acquires Biocrates to Boost Metabolomics Solutions - GuruFocus
Bruker Corp (BRKR) 財務データ
収益
当期純利益
現金流量
EPS
1.27%
大文字化:
|
ボリューム (24 時間):